Biote (BTMD) Price-to-Operating-Cash-Flow : 2.79 (As of May. 30, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Biote Price-to-Operating-Cash-Flow?

As of today (2025-05-30), Biote's share price is $3.595. Biote's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $1.29. Hence, Biote's Price-to-Operating-Cash-Flow Ratio for today is 2.79.

The historical rank and industry rank for Biote's Price-to-Operating-Cash-Flow or its related term are showing as below:

BTMD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.86 Med: 4 Max: 11.2
Current: 2.79

During the past 6 years, Biote's highest Price-to-Operating-Cash-Flow Ratio was 11.20. The lowest was 1.86. And the median was 4.00.

BTMD's Price-to-Operating-Cash-Flow is ranked better than
91.94% of 496 companies
in the Healthcare Providers & Services industry
Industry Median: 11.655 vs BTMD: 2.79

Biote's Cash Flow from Operations per share for the three months ended in Mar. 2025 was $0.18. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $1.29.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Biote was 72.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -33.30% per year.

During the past 6 years, Biote's highest 3-Year average Operating Cash Flow per Share Growth Rate was -33.10% per year. The lowest was -33.30% per year. And the median was -33.20% per year.

Biote Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Biote's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biote Price-to-Operating-Cash-Flow Chart

Biote Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

4.72

4.68

Biote Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial												7.74	10.33	4.65	4.68	2.58

Competitive Comparison of Biote's Price-to-Operating-Cash-Flow

For the Medical Care Facilities subindustry, Biote's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biote's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Biote's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Biote's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Biote Price-to-Operating-Cash-Flow Calculation

Biote's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	3.595	/	1.289
	=	2.79

Biote's Share Price of today is $3.595.
Biote's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.29.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Biote Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Biote's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Biote Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Biote Corp (NAS:BTMD) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

1875 West Walnut Hill Lane, Suite 100, Irving, TX, USA, 75038

Website

https://www.biote.com

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.

Executives

Guines Llc	10 percent owner	767 THIRD AVENUE, 29TH FLOOR, NEW YORK NY 10017
Stephen Mark Cone	director	C/O BIOTE CORP., 1875 W. WALNUT HILL LN #100, IRVING TX 75038
Marc D Beer	director	C/O AEGERION PHARMACEUTICALS, 89 HEADQUARTERS PLAZA, SUITE 1212, MORRISTOWN NJ 07960
Andrew R Heyer	director, officer: President and Director	501 MADISON AVENUE, FLOOR 5, NEW YORK NY 10019
Mary Elizabeth Conlon	officer: General Counsel	C/O BIOTE CORP., 1875 W. WALNUT HILL LN #100, IRVING TX 75038
Daniel M. Friedberg	10 percent owner	C/O SAGARD CAPITAL, 325 GREENWICH AVENUE, GREENWICH CT 06830
Anil K Shrivastava	10 percent owner	200 PARK AVENUE, 17TH FLOOR, NEW YORK NY 10016
Michael David Braner	10 percent owner	200 PARK AVENUE, 17TH FLOOR, NEW YORK NY 10016
325 Capital Llc	10 percent owner	757 THIRD AVENUE, 20TH FLOOR, NEW YORK NY 10017
Mary Joan Puncochar	officer: Chief Commercial Officer	C/O BIOTE CORP., 1875 W. WALNUT HILL LN #100, IRVING TX 75038
Samar Jagat Kamdar	officer: Chief Financial Officer	7042 CORONADO AVE., DALLAS TX 75214
Roystone Capital Management Lp	10 percent owner	780 THIRD AVENUE, 41ST FLOOR, NEW YORK NY 10017
Debra L Morris	director	11620 WILSHIRE BOULEVARD, SUITE 1000, LOS ANGELES CA 90025
Roystone Capital Holdings Llc	10 percent owner	767 THIRD AVENUE, 29TH FLOOR, NEW YORK NY 10017
Teresa Sue Weber	director, officer: Chief Executive Officer	C/O BIOTE CORP., 1875 W. WALNUT HILL LN #100, IRVING TX 75038